BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25670009)

  • 21. [Effect of competition-oriented reform in the Netherlands health care system on the relationship between primary care physicians, insurance groups and insured patients].
    Groenewegen PP; Gress S
    Gesundheitswesen; 2000 Nov; 62(11):568-76. PubMed ID: 11151698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease management and health care reforms in Germany - does more competition lead to less solidarity?
    Stock SA; Redaelli M; Lauterbach KW
    Health Policy; 2007 Jan; 80(1):86-96. PubMed ID: 16600418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring customer preferences in the German statutory health insurance.
    Pendzialek JB; Simic D; Stock S
    Eur J Health Econ; 2017 Sep; 18(7):831-845. PubMed ID: 27655398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pricing behaviour of nonprofit insurers in a weakly competitive social health insurance market.
    Douven RC; Schut FT
    J Health Econ; 2011 Mar; 30(2):439-49. PubMed ID: 21295365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Health care structure legislation--reform of health insurance].
    Pick P
    Gesundheitswesen; 1993 Mar; 55(3):140-5. PubMed ID: 8471809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public option and private profits: what do markets expect?
    Milani F
    Appl Health Econ Health Policy; 2010; 8(3):155-65. PubMed ID: 20201607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Market-based reform: what to regulate and by whom.
    Enthoven AC; Singer SJ
    Health Aff (Millwood); 1995; 14(1):105-19. PubMed ID: 7657195
    [No Abstract]   [Full Text] [Related]  

  • 29. Insurance market reform and the cost-containment imperative.
    Gradison B
    Acad Med; 1995 Mar; 70(3):214-5. PubMed ID: 7873009
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk selection in the German public health insurance system.
    Nuscheler R; Knaus T
    Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of asymmetric medical insurance subsidy on hospitals competition under non-price regulation.
    Wang C; Nie PY
    Int J Equity Health; 2016 Nov; 15(1):184. PubMed ID: 27846902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optional deductibles in social health insurance systems: findings from Germany.
    Pütz C; Hagist C
    Eur J Health Econ; 2006 Dec; 7(4):225-30. PubMed ID: 16802119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. German health reform likely to raise costs for patients.
    Tuffs A
    BMJ; 2004 Jan; 328(7431):70. PubMed ID: 14715600
    [No Abstract]   [Full Text] [Related]  

  • 36. Health reform: examining the alternatives.
    Custer W
    EBRI Issue Brief; 1994 Mar; (147):1-40. PubMed ID: 10134010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A free market is unfavourable for health care].
    Kant A
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1015. PubMed ID: 16715865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What kind of healthcare 'internal market'? A cross-Europe view of the options.
    Sheaff R
    Int J Health Plann Manage; 1994; 9(1):5-24. PubMed ID: 10137133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economics of health care reform.
    Naslund MJ
    Urology; 1994 Sep; 44(3):299-304. PubMed ID: 8073543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competition policy for health care provision in Germany.
    Kifmann M
    Health Policy; 2017 Feb; 121(2):119-125. PubMed ID: 27908564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.